Since lung inflammation is one of the most common concerns in COVID-19 patients, we wanted to test whether WS extract has the potential to inhibit LPS-induced inflammation in the lung-derived cell lines and in the mice model of acute lung inflammation in a TLR-4-dependent manner. Here, TLR4 is linked to inflammation.